Analyzing TransEnterix (TRXDW) and Its Competitors

Profitability

This table compares TransEnterix and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TransEnterix	-2,149.15%	-83.74%	-64.94%
TransEnterix Competitors	-672.41%	-133.75%	-59.01%

Valuation and Earnings

This table compares TransEnterix and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
TransEnterix	$8.53 million	-$154.20 million	-0.04
TransEnterix Competitors	$58.84 million	-$32.15 million	4.18

TransEnterix’s peers have higher revenue and earnings than TransEnterix. TransEnterix is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

TransEnterix has a beta of 2.56, indicating that its stock price is 156% more volatile than the S&P 500. Comparatively, TransEnterix’s peers have a beta of 1.76, indicating that their average stock price is 76% more volatile than the S&P 500.

Institutional & Insider Ownership

8.2% of TransEnterix shares are owned by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by institutional investors. 3.1% of TransEnterix shares are owned by insiders. Comparatively, 18.1% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

TransEnterix peers beat TransEnterix on 7 of the 9 factors compared.

About TransEnterix

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.